Newsroom

HOUSTON--(BUSINESS WIRE)--Oceaneering Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call for February 18/February 19....

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at...

SEATTLE--(BUSINESS WIRE)--As previously disclosed, on December 27, 2024, WaFd Bank (the “Bank”), a wholly-owned subsidiary of WaFd, Inc. (the “Company”), received an overall CRA rating from the Federal Deposit Insurance Corporation (“FDIC”) of “Needs to Improve” for the period spanning June 3, 2020 to March 26, 2024. The Bank appealed the FDIC’s rating to the Supervision Appeals Review Committee of the FDIC (“SARC”). On January 16, 2026, the SARC issued its decision to grant the Bank’s appeal a...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the combination of Trodelvy® (sacituzumab govitecan-hziy) plus Keytruda® (pembrolizumab) in first-line PD-L1+ (CPS ≥10) metastatic triple-negative breast cancer (TNBC). ASCENT-04 successfully met its primary endpoint of progression-free survival (PFS) with a 35% (HR: 0.65;...

BOSTON--(BUSINESS WIRE)--Board, een van de toonaangevende Enterprise Planning Platforms, kondigde vandaag de lancering aan van Board Agents gebouwd op Microsoft Foundry. Board Agents levert een intelligente reeks domeinspecifieke, bedrijfsklare AI agents die praktische planningsbeslissingen ondersteunen in financiën, de toeleveringsketen en merchandising. Dit is de eerste Board bedrijfsplanningscapaciteit ontwikkeld met Microsoft Foundry, waarbij gebruik wordt gemaakt van Microsoft Azure’s agen...

ATLANTA--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (NYSE: PNFP) reported net income per diluted common share of $2.13 for the quarter ended Dec. 31, 2025, for the business of legacy Pinnacle Financial Partners, Inc., compared to net income per diluted common share of $1.91 for the quarter ended Dec. 31, 2024, an increase of approximately 11.5 percent. Net income per diluted common share was $8.07 for the year ended Dec. 31, 2025, compared to net income per diluted common share of $5.96...

BOSTON--(BUSINESS WIRE)--A Board, uma das principais plataformas de planejamento empresarial, anunciou hoje o lançamento da Board Agents desenvolvida na Microsoft Foundry. A Board Agents oferece um conjunto inteligente de agentes de IA específicos para cada domínio e prontos para uso empresarial, que apoiam decisões de planejamento no mundo real em finanças, cadeia de suprimentos e merchandising. Esta é a primeira funcionalidade de planejamento empresarial da Board desenvolvida com a Microsoft...

COLUMBUS, Ga.--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (NYSE: PNFP) today reported financial results for Synovus Financial Corp. (“Synovus” or “legacy Synovus”) for the quarter and year ended Dec. 31, 2025. “Pinnacle and Synovus both delivered strong results in 2025, demonstrating our commitment to growth amid the pending merger,” said Pinnacle President and CEO Kevin Blair. “Legacy Pinnacle grew diluted EPS by 35% and adjusted diluted EPS by 22%, while legacy Synovus achieved increa...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RAPT Therapeutics, Inc. (NasdaqGM: RAPT) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of RAPT will receive $58.00 in cash for each share of RAPT that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or...